Skip to main content
SpringerLink
Log in

Farmaci e gravidanza

  • Chapter
Book cover Medicina dell’età prenatale

  • 635 Accesses

Estratto

La maggior parte dei farmaci somministrata ad una gestante è in grado di attraversare la barriera placentare per cui il prodotto del concepimento puè risentirne gli effetti spesso innocui, talora benefici, talvolta dannosi. In questo capitolo saranno presi in considerazione i possibili rischi teratogeni.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Little BB, Gilstrap LC, Cunningham FG (1991) Medication use during pregnancy. Part 1 Concept of human teratology Williams Obstetrics, 18th edn, Supplement 10. Appleton&Lange, Norwalk

    Google Scholar 

  2. Yankowitz J (2001) Use of medications in pregnancy: general principles, teratology and current developments. In: Yankowitz J, Niebyl JR (eds) Drug therapy in pregnancy, Lippincott Williams and Wilkins, Philadelphia

    Google Scholar 

  3. Grella PV (1987) Farmacoterapia in gravidanza. In: Ambrosini A (ed) Ginecologia e ostetricia. Monduzzi Ed, Bologna

    Google Scholar 

  4. Grella PV (1996) Terapie farmacologiche materne e fetali. In: Candiani GB, Danesino V, Gastaldi A (eds) La clinica ostetrica e ginecologica. Masson, Milano

    Google Scholar 

  5. Mucklow JC (1986) The fate of drugs in pregnancy. Clin Obstet Gynecol 13:161–175

    CAS  Google Scholar 

  6. Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in pregnancy and lactation. Lippincot Williams and Wilkins, Hagerstown

    Google Scholar 

  7. Friedman JM, Polifka JE (2000) Teratogenic effects of drugs: a resource for clinicians (TERIS). Johns Hopkins University Press, Baltimora

    Google Scholar 

  8. Heinonen PO, Slone D, Shapiro S (1977) Birth defect and drugs in pregnancy. Publishing Sciences Group, Littleton

    Google Scholar 

  9. Aselton P, Jick H, Milunski A et al (1985) First trimester drug use and congenital disorders. Obstet Gynecol 65:451–455

    PubMed  CAS  Google Scholar 

  10. Pescetto G, De Cecco L, Pecorari D, Ragni N (1990) Manuale di ginecologia e ostetrida. Sodetà Editrice Universo, Roma

    Google Scholar 

  11. Briggs GG, Freeman RK, Yaffe SJ (2001) Drugs in pregnancy and lactaction. 6th ed. Lippincott Williams and Wilkins, Philadelphia, p 501

    Google Scholar 

  12. Desmonts G, Couvreur J (1974) Congenital toxoplasmosis: a prospective study of 378 pregancies. N Eng J Med 290:1110–1116

    Article  CAS  Google Scholar 

  13. Einarson A, Phillips E, Mawji F et al (1998) A prospective controlled multicentre study of clarithromycin in pregnancy. Am J Perinatol 15:523–525

    PubMed  CAS  Google Scholar 

  14. Donald PR, Doherty E, Van Zyl FJ (1991) Hearing loss in the child following streptomycin administration during pregnancy. Cent Afr J Med 37:268–271

    PubMed  CAS  Google Scholar 

  15. Nishimura H, Tanimura T (1976) Clinical aspects of the teratogenicity of drugs. Excerpta Medica, Amsterdam

    Google Scholar 

  16. Robinson GC, Cambon KG (1964) Hearing loss in infants of tuberculous mothers treated with streptomycin during pregnancy. N Engl J Med 271:949–951

    Article  PubMed  CAS  Google Scholar 

  17. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. (2000) A teratological study of aminoglycoside antibiotic treatment during pregnancy. Scand J Infect Dis 32:309–313

    Article  PubMed  CAS  Google Scholar 

  18. Briggs GG, Freeman RK, Yaffe SJ (2002) Drugs in pregnancy and lactation. 6th ed. Lippincott Williams and Wilkins, Philadelphia, p 1324

    Google Scholar 

  19. Kline AH, Blattner RJ, Lunin M (1964) Transplacental effects of tetracycline on teeth. JAMA 118:178–180

    Google Scholar 

  20. Landers DV, Green JR, Sweet RL (1983) Antibiotic use during pregnancy and the postpartum period. Clin Obstet Gynecol 26:391–406

    Article  PubMed  CAS  Google Scholar 

  21. Colley DP, Kay J, Gibson GT (1982) A study of the use in pregnancy of co-trimoxazole and sulfamethizole. Aust J Pharm 63:570–575

    Google Scholar 

  22. Briggs GG, Freeman RK, Yaffe SJ (2002) Drugs in pregnancy and lactation. 6th ed. Lippincott Williams and Wilkins, Philadelphia, p 1393

    Google Scholar 

  23. Pescetto G, De Cecco L, Pecorari D, Ragni N (1990) Manuale di ginecologia e ostetricia. Società Editrice Universo, Roma

    Google Scholar 

  24. Briggs GG, Freeman RK, Yaffe SJ (2002) Drugs in pregnancy and lactation. 6th ed. Lippincott Williams and Wilkins, Philadelphia, p 286

    Google Scholar 

  25. Gilstrap LC, Little BB, Cunningham FG (1991) Medication use during pregnancy. Part 2. Special considerations. Williams Obstetrics, 18th edn, Supplement 11. Appleton&Lange, Norwalk

    Google Scholar 

  26. Rosa FW, Baum C, Shaw M (1987) Pregnancy outcomes after first trimester vaginitis drug therapy. Obstet Gynecol 69:751–755

    PubMed  CAS  Google Scholar 

  27. Ismail MA, Lerner SA (1982) Disseminated blastomycosis in a pregnant woman: review of amphotericin B usage during pregnancy. Am Rev Respir Dis 126:350–353

    PubMed  CAS  Google Scholar 

  28. Snider DE Jr, Layde PM, Johnson MW, Lyle MA (1980) Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 122:65–79

    PubMed  Google Scholar 

  29. Medchill MT, Gillum M (1989) Diagnosis and management of tuberculosis during pregnancy. Obstet Gynecol Surv 44:81–84

    Article  PubMed  CAS  Google Scholar 

  30. Varpela E (1964) On the effect exerted by first line tuberculosis medicines on the foetus. Acta Tuberc Scand 35:53–69

    Google Scholar 

  31. Briggs GG, Freeman RK, Yaffe SJ (2002) Drugs in pregnancy and lactation. 6th ed. Lippincott Williams and Wilkins, Philadelphia, p 598

    Google Scholar 

  32. Hammill HA (1989) Metronidazole, clindamycin, and quinolones. Obstet Gynecol Clin N Am 16:317–328

    CAS  Google Scholar 

  33. Czeizel AE, Rockenbauer M (1998) A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 105:322–327

    PubMed  CAS  Google Scholar 

  34. Wolfe MS Cordero JF (1985) Safety of chloroquine in chemosuppression of malaria during pregnancy. Brit Med J 290:1466–1467

    CAS  Google Scholar 

  35. Sperling RS, Stratton P, O’Sullivan MJ et al (1992) A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. N Eng J Med 326:857–861

    Article  CAS  Google Scholar 

  36. Andrews EB, Yankaskas BC, Cordero JF et al (1992) Acyclovir in pregnancy registry: six years experience. Obstet Gynecol 79:7–13

    PubMed  CAS  Google Scholar 

  37. Mendelson CL (1970) Cardiac disease in pregnancy: medical care, cardiovascular surgery and obstetric mangement as related to maternal and foetal welfare. FA Davis Ed, Philadelphia

    Google Scholar 

  38. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, p 293

    Google Scholar 

  39. Murad SH, Tabsh KM, Shilyanski G et al (1985) Effect of verapamil on uterine blood flow and maternal cardiovascular function in the awake pregnant ewe. Anest Analg 64:7–10

    Article  CAS  Google Scholar 

  40. Kleinman CS, Copel JA (1991) Electrophysiological principles and fetal antiarrhythmic therapy. Ultras Obstet Gynecol 1:286–297

    Article  CAS  Google Scholar 

  41. Lingman G, Ohrlander S, Ohlin P (1980) Intrauterine digoxin treatment of fetal paroxysmal tachicardia: case report. Brit J Obstet Gynaecol 87:340–342

    CAS  Google Scholar 

  42. Rotmensch HH, Rotmensch S, Elkayam U (1987) Management of cardiac arrhythmias during pregnancy: current concepts. Drugs 33:623–633

    Article  PubMed  CAS  Google Scholar 

  43. Rotmensch HH, Elkayam U, Frishman W (1983) Antiarrhythmic drug therapy during pregnancy. Ann Int Med 98:487–497

    PubMed  CAS  Google Scholar 

  44. Niebyl JR (1996) Drugs in pregnancy and lactation. In Gabbe SG, Niebyl JL, Simpson JR (1996) Obstetrics. Normal and problem pregnancies. Churchill Livingstone, Edimburgh

    Google Scholar 

  45. Horvath JS, Phippard A, Korda A et al (1985) Clonidine hydrocloride — a safe and effective anthypertensive agent in pregnancy. Obstet Gynecol 66:634–638

    PubMed  CAS  Google Scholar 

  46. Bortolus R, Ricci E, Chatenoud L, Parazzini F (2000) Nifedipine administred in pregnancy: effect in the development of children et 18 mounths. Brit J Obstet Gynaecol 107:792–794

    CAS  Google Scholar 

  47. Pruyn SC, Phelan JP, Buchanan GC (1979) Long term propanolol therapy in pregnancy: maternal and fetal outcome. Am J Obstet Gynecol 135:485–489

    PubMed  CAS  Google Scholar 

  48. Butters L, Kennedy S, Rubin PC (1990) Atenololo in essential hypertension during pregnancy. BJM 301:587–589

    CAS  Google Scholar 

  49. Rosa F, Bosco L (1991) Infant renal failure with maternal ACE inhibitors. Am J Obstet Gynecol 164:273

    Google Scholar 

  50. Boutroy MJ, Vert P, Hurault de Ligny BH, Miton A (1984) Captopril administration in pregnancy impairs fetal angiotensin converting enzyme activity and neonatal adaptation. Lancet 2:935–936

    Article  PubMed  CAS  Google Scholar 

  51. Milner RD (1972) Neonatal hypoglycaemia — a critical reappraisal. Arch Dis Childhood 255:679–682

    Google Scholar 

  52. Rodriguez SU, Leikin SL, Hiller MC (1964) Neonatal thrombocytopenia associated with antepartum administration of thiazide drugs. N Engl J Med 270:881–884

    Article  PubMed  CAS  Google Scholar 

  53. Hirsch KS, Wilson JG, Scott WJ, O’Flaherty EJ (1983) Acetazolamide teratology ad its association with carbonic anhydrase inhibition in the mouse. Terat Carcinog Mutag 3:133–144

    Article  CAS  Google Scholar 

  54. Hecker A, Hasan SH, Neumann F (1980) Disturbances in sexual differentiation of rat foetus following spironolactone treatment. Acta Endocrinol 95:540–545

    PubMed  CAS  Google Scholar 

  55. Hall JG, Pauli RM, Wilson K (1980) Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68:122–140

    Article  PubMed  CAS  Google Scholar 

  56. Barbour LA (1997) Current concepts of anticoagulant therapy in pregnancy. Obstet Gynecol Clin North Am 24:499–521

    Article  PubMed  CAS  Google Scholar 

  57. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, pp 339, 356, 579

    Google Scholar 

  58. Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A (1999) Tocolytics for preterm labor: a systematic review. Obstet Gynaecol 94:896–877

    Article  Google Scholar 

  59. Mittendorf R, Pryde PG (2000) An overview of the possible relationship between antenatal farmacologic magnesium and cerebral palsy. J Perit Med 28:286–293

    Article  CAS  Google Scholar 

  60. King JF, Flenady VJ, Papatsonis DN et al (2002) Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev (2):CD002255

    PubMed  Google Scholar 

  61. The Worldwide Atosiban v/s Beta Agonist Study Group (2001) Effectiveness and safety of the oxytocin antagonist atosiban v/s beta adrenergic agonists in the treatment of preterm labour. Brit J Obstet Gynaecol 108:133–142

    Article  Google Scholar 

  62. Di Renzo GC, Rosati A, Mignosa MM et al (2002) Gli antagonisti dell’ossitocina come tocolitici. Atti Società Italiana Ginecologia ostetricia, CIC Ed. Internazionali, Roma, pp 524–527

    Google Scholar 

  63. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova,p 163

    Google Scholar 

  64. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, pp 172–175

    Google Scholar 

  65. Tamer A, Mc Key R, Arias D et al (1969) Phenothiazine-induced extrapyramidal dysfunction in the neonate. J Pediatr 75:479–480

    Article  PubMed  CAS  Google Scholar 

  66. Robertson RT, Majka JA, Peter CP et al (1980) Effects of prenatal exposure to chlorpromazine on postnatal development and behavior of rats. Toxicol Appl Pharmacol 53:541–549

    Article  PubMed  CAS  Google Scholar 

  67. Van Waes A, Van de Velde E (196) Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum. J Clin Pharmacol 9:224–227

    Google Scholar 

  68. Barnas C, Bergant A, Hummer M et al (1994) Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk. Am J Psychiatry 151:945

    PubMed  CAS  Google Scholar 

  69. Milkovich L, Van de Berg BJ (1976) An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol 125:244–248

    Google Scholar 

  70. Safra MJ, Oakley GP (1975) Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 2:478–480

    Article  PubMed  CAS  Google Scholar 

  71. Braken MB, Holford TR (1981) exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol 58:336–344

    Google Scholar 

  72. Czeizel A (1988) Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. Reproduc Toxicol 1:183–188

    Article  CAS  Google Scholar 

  73. Bracken MB (1986) Drug use in pregnancy and congenital heart disease in offspring. N Engl J Med 314:1120

    PubMed  CAS  Google Scholar 

  74. Di Michele V, Ramenghi LA, Sabatino G (1996) Clozapine and lorazepam administration in pregnancy. Europ Psychiatry 11:214

    Article  Google Scholar 

  75. Morrow AW (1972) Imipramine and congenital abnormalities. N Zeal Med J 75:228–229

    CAS  Google Scholar 

  76. Scanion FJ (196) Use of antidepressant drugs during the first trimester. Med J Aust 2:1077

    Google Scholar 

  77. Altshuler L, Cohen L, Szuba MP et al (1996) Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 153:592–606

    PubMed  CAS  Google Scholar 

  78. Eggermont E (1973) Withdrawal symptoms in neonates associated with maternal imipramine therapy. Lancet 2:680

    Article  PubMed  CAS  Google Scholar 

  79. Cowe L, Lloyd D, Dawling S (1982) Neonatal convulsions caused by with drawal from maternal clomipramine. BMJ 284:1837–1838

    Article  PubMed  CAS  Google Scholar 

  80. Goldstein DJ, Marvel DE (1993) Psychotropic medications during pregnancy: risk to the fetus. JAMA 270:2177

    Article  PubMed  CAS  Google Scholar 

  81. Pastuszak A, Schick-Boschetto B, Zuber C et al (1993) Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 269:2246–2248

    Article  PubMed  CAS  Google Scholar 

  82. Chambers CD, Johnson KA, Dick LN et al (1996) Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335:1010–1015

    Article  PubMed  CAS  Google Scholar 

  83. Kulin NA, Pastuszak A, Sage SR et al (1998) Pregnancy outcome following maternal use of the new selective serotonine reuptake inhibitors. JAMA 279:609–610

    Article  PubMed  CAS  Google Scholar 

  84. Schou M, Goldfield MD, Weinstein MR et al (1973) Lithium and pregnancy. Report from the register of lithium babies. BMJ 2:135–136

    PubMed  CAS  Google Scholar 

  85. Jacobson SJ, Jones K, Johnson K et al (1992) Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 339:530–533

    Article  PubMed  CAS  Google Scholar 

  86. Zalstein E, Koren G, Einarson T et al (1990) A case control study on the association between 1st trimester exposure to lithium and Ebstein’s anomaly. Am J Cardiol 65:817–818

    Article  Google Scholar 

  87. Ananth J (1976) Side effects of fetus and infants of psycotropic drug use during pregnancy. Pharmacopsychiatry 11:246–260

    CAS  Google Scholar 

  88. Cohen LS, Sichel DA, Robertson LM et al (1995) Postpartum prophilaxis for women with bipolar disorder. Am J Psychiatry 152:1641–1645

    PubMed  CAS  Google Scholar 

  89. Hanson JW, Smith DW (1975) The fetal hydantoin syndrome. J Pediat 87:285–290

    Article  PubMed  CAS  Google Scholar 

  90. Jager Roman E, Deichl A, Jakob S et al (1986) Fetal growth, major malformations and minor anomalies in infants born to women receiving valproic acid. J Pediat 108:997–1004

    Article  PubMed  CAS  Google Scholar 

  91. Agapitos M, Georgiou-Theodoropoulou M, Koutselinis A, Papacharalampus N (1986) Cyclopia and maternal ingestion of salicylates. Pediat Pathol 6:309–310

    Article  CAS  Google Scholar 

  92. Slone D, Siskind V, Heinonen OP et al (1976) Aspirin and congenital malformations. Lancet i: 1373–1375

    Article  Google Scholar 

  93. Turner G, Collins E (1975) Fetal effects of regular salicylate ingestion in pregnancy. Lancet ii:338–339

    Article  Google Scholar 

  94. Levin DL, Fixier DE, Morris FC, Tyson J (1978) Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors. J Pediat 92:478–483

    Article  PubMed  CAS  Google Scholar 

  95. Manchester D, Margolis HS, Sherldon RE (1976) Possible association between maternal indomethacin therapy and primary pulmonary hypertension in the newborn. Am J Obstet Gynecol 126:467–469

    PubMed  CAS  Google Scholar 

  96. Csaba I, Sulyok FE, Ertl T (1978) Relationship of maternal treatment with indomethacin to persistence of fetal circulation syndrome. J Pediat 92:484

    Article  PubMed  CAS  Google Scholar 

  97. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, pp 539–544, 552

    Google Scholar 

  98. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, pp 389, 392, 395

    Google Scholar 

  99. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, pp 399, 402–406, 408–414

    Google Scholar 

  100. Dombrowski MP (1997) Pharmacologic therapy of asthma during pregnancy. Obstet Gynecol Clin N Am 24:559

    Article  CAS  Google Scholar 

  101. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, pp 419–422

    Google Scholar 

  102. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, pp 427–430

    Google Scholar 

  103. Warkany J (1978) Aminopterin and methotrexate: folic acid deficiency. Teratology 17:353–358

    Article  PubMed  CAS  Google Scholar 

  104. Diamond I, Anderson MM, Mc Creadie SR (1960) Transplacental trasmission of busulfan in a mother with leukemia. Production of fetal malformations and cytomegaly. Pediatrics 25:85–90

    PubMed  CAS  Google Scholar 

  105. Kirshon B, Wasserstrum N, Willis R et al (1988) Teratogenic effects of first trimester cyclophosphamide therapy. Obstet Gynecol 72:462–464

    PubMed  CAS  Google Scholar 

  106. Metz SA, Day TG, Pursell SH (1989) Adjuvant chemotherapin a pregnant patient with endodermal sinus tumor of the ovary. Gynecol Oncol 32:371–374

    Article  PubMed  CAS  Google Scholar 

  107. Doll DC, Ringenberg S, Yarbro JW (1988) Management of cancer during pregnancy. Arch Int Med 148:2058–2064

    Article  CAS  Google Scholar 

  108. Milham S, Elledge W (1972) Maternal methimazole and congenital defects in children. Teratology 5:125

    Article  Google Scholar 

  109. Momotani N, Ito K, Hamada N et al (1984) Maternal hyperthyroidism and congenital malformations in the offspring. Clin Endocrinol 20:695–700

    CAS  Google Scholar 

  110. Chiovato L, Pinchera A, Crosignani PG (1998) Tiroide e gravidanza. Mediserve, Milano

    Google Scholar 

  111. Kingsbury AC(1985) Danazol and fetal masculinization: a warning. Med J Aust 143:410–411

    Google Scholar 

  112. Sandberg EC, Riffle NL, Higdon JW et al (1981) Pregnancy outcome in women exposed to diethylstilbestrol in utero. Am J Obstet Gynecol 104:194–205

    Google Scholar 

  113. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, p 476

    Google Scholar 

  114. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, pp 72, 216, 226–228

    Google Scholar 

  115. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, pp 580–584

    Google Scholar 

  116. Onnis A, Grella P (1977) I farmaci in gravidanza. Piccin Ed, Padova, pp 579–585

    Google Scholar 

  117. Dai WS, Labraico JM, Stern SR (1992) Epidemiology of isotretionin exposure during pregnancy. J Am Acad Dermatol 26:599–606

    Article  PubMed  CAS  Google Scholar 

  118. Pescetto G, De Cecco L, Pescatori D, Ragni N (2001) Ginecologia e Ostetricia, Vol II Ostetricia, Società Editrice Universo, Roma, pp 1151

    Google Scholar 

  119. AIFA (Agenzia Italiana del Farmaco), Ministero della Salute (2005) Farmaci in gravidanza. Istituto Poligrafica e Zecca dello Stato SpA, Roma

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro di Diagnosi Prenatale Dipartimento di Scienze Ginecologiche Ostetriche e della Riproduzione, II Università degli Studi di Napoli, Napoli

    Antonio L. Borrelli, Maria Felicetti & Giuseppe Feroce

Authors
  1. Antonio L. Borrelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Felicetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Feroce
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Italia

About this chapter

Cite this chapter

Borrelli, A.L., Felicetti, M., Feroce, G. (2008). Farmaci e gravidanza. In: Medicina dell’età prenatale. Springer, Milano. https://doi.org/10.1007/978-88-470-0688-1_29

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-0688-1_29

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0687-4

  • Online ISBN: 978-88-470-0688-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation